"Hemolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Descriptor ID |
D006461
|
| MeSH Number(s) |
C23.550.403 G12.122.545
|
| Concept/Terms |
Extravascular Hemolysis- Extravascular Hemolysis
- Extravascular Hemolyses
- Hemolyses, Extravascular
- Hemolysis, Extravascular
Intravascular Hemolysis- Intravascular Hemolysis
- Hemolyses, Intravascular
- Hemolysis, Intravascular
- Intravascular Hemolyses
|
Below are MeSH descriptors whose meaning is more general than "Hemolysis".
Below are MeSH descriptors whose meaning is more specific than "Hemolysis".
This graph shows the total number of publications written about "Hemolysis" by people in this website by year, and whether "Hemolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemolysis" by people in Profiles.
-
Reducing Specimen Rejection Rates Using Concentration-Dependent Hemolysis Rejection Thresholds. J Appl Lab Med. 2023 03 06; 8(2):285-295.
-
Use of a Vanadate Oxidation Conjugated Bilirubin Assay to Reduce Test Cancellations Resulting from Hemolyzed Specimens in Pediatric Patients. Am J Clin Pathol. 2023 01 04; 159(1):6-9.
-
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion. 2022 07; 62(7):1446-1451.
-
Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation. J Exp Med. 2021 06 07; 218(6).
-
Chlorine inhalation induces acute chest syndrome in humanized sickle cell mouse model and ameliorated by postexposure hemopexin. Redox Biol. 2021 08; 44:102009.
-
Sex difference in the impact of smoking on left ventricular assist device outcomes. J Card Surg. 2020 Nov; 35(11):2913-2919.
-
Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay. Clin Chim Acta. 2020 Oct; 509:293-294.
-
Effect of tobacco smoking on outcomes after left ventricular assist device implantation. Artif Organs. 2020 Jul; 44(7):693-699.
-
Phosgene inhalation causes hemolysis and acute lung injury. Toxicol Lett. 2019 Sep 15; 312:204-213.
-
Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. J Clin Apher. 2019 Feb; 34(1):64-72.